Does a Combination Regimen of Thyroxine (T4) and 3,5,3′-Triiodothyronine Improve Depressive Symptoms Better Than T4Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Some hypothyroid patients receiving levothyroxine replacement therapy complain of depressive symptoms despite normal TSH measurements. It is not known whether adding T(3) can reverse such symptoms. We randomized 40 individuals with depressive symptoms who were taking a stable dose of levothyroxine for treatment of hypothyroidism (excluding those who underwent thyroidectomy or radioactive iodine ablation of the thyroid) to receive T(4) plus placebo or the combination of T(4) plus T(3) in a double-blind manner for 15 wk. Participants receiving combination therapy had their prestudy dose of T(4) dropped by 50%, and T(3) was started at a dose of 12.5 micro g, twice daily. T(4) and T(3) doses were adjusted to keep goal TSH concentrations within the normal range. Compared with the group taking T(4) alone, the group taking both T(4) plus T(3) did not report any improvement in self-rated mood and well-being scores that included all subscales of the Symptom Check-List-90, the Comprehensive Epidemiological Screen for Depression, and the Multiple Outcome Study (P > 0.05 for all indexes). In conclusion, the current data do not support the routine use of combined T(3) and T(4) therapy in hypothyroid patients with depressive symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another trial was conducted in those with depressive symptoms (60).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [60]
In the citing paper
“Eleven trials were 5–16 weeks (23,46,49,51–53,58–60,71,79), three trials were 4–6 months (17,48,78), and one trial was 1 year in duration (47).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [60]
In the citing paper
“There was no significant difference in Heart Rate, SHBG, TSH, Lipid profile, TSQ-36, and BDI Score.”
In the citing paper
“Most of the included studies are insignificant [9, 12–18] except for two studies, one showed a lower TSH, and the other showed a higher TSH [19, 20].”
In the citing paper
“The daily L-T3 dose was administered as a single dose in all trials except four, in which it was divided in two doses [37,40,42,43] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [43]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
A scaled version of the General Health Questionnaire
Goldberg, D. P., & Hillier, V. F. (1979) · Psychological Medicine · doi:10.1017/s0033291700021644 · Cited by 5,459
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 4,633
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
Derogatis, L. R., Rickels, K., & Rock, A. F. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.3.280 · Cited by 2,298
Hays, R. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130011002 · Cited by 841
The Center for Epidemiologic Studies Depression Scale: its use in a community sample
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.1.41 · Cited by 804
McHorney, C. A., Ware, J. E., Rogers, W., Raczek, A. E., & Lu, J. F. R. (1992) · Medical Care · doi:10.1097/00005650-199205001-00025 · Cited by 740
Conversion of Thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects
Braverman, L. E., Ingbar, S. H., & Sterling, K. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106304 · Cited by 485
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationRoberts, C. G., & Ladenson, P. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15696-1 · Cited by 567
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296
“Sawka 2003 (16) No B, not specified A, central allocation by pharmacy No Triple blind SCL 90; MOS”
BackgroundTreatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction
Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hennessey, J. V., Kopp, P. A., Ross, D. S., Samuels, M. H., Sawka, A. M., et al. (2018) · Thyroid · doi:10.1089/thy.2017.0681 · Cited by 231
Self-citationThyroid-hormone therapy and thyroid cancer: a reassessment
Biondi, B., Filetti, S., & Schlumberger, M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0020 · Cited by 224
Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy
Jonklaas, J. (2008) · JAMA · doi:10.1001/jama.299.7.769 · Cited by 216
“Some of these studies have flaws, such as production of iatrogenic hyperthyroidism with therapy,(19,25,27,28) small sample size,(20,27,28,30) different TSH levels in treatment groups,(29,30) failure to use athyreotic patients,(22,25,27) and failure to replicate the normal molar ratio of T4:T3.(19,21-23,25,29) Addition…”
BackgroundAppelhof, B. C., Fliers, E., Wekking, E. M., Schene, A. H., Huyser, J., Tijssen, J. G. P., Endert, E., van Weert, H. C. P. M., & Wiersinga, W. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2111 · Cited by 183
“80 Positive TPO-ab (n, %) 38 (79) 37 (80) 36 (78) Current major depressive disorder (n, %) 3 (6) 4 (9) 3 (7)”
Escobar-Morreale, H. F., Botella-Carretero, J. I., Gómez-Bueno, M., Galán, J. M., Barrios, V., & Sancho, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00007 · Cited by 182
“However, 2 of these studies had a parallel-group design (10, 11), and in the study that included a crossover design, serum TSH levels were higher after triiodothyronine substitution than after treatment with L-thyroxine alone (9), suggesting undertreatment with the former agent (12).”
BackgroundJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Self-citationTreatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine
Escobar-Morreale, H. F., Botella-Carretero, J. I., del Rey, F. E., & de Escobar, G. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0184 · Cited by 160
“(37) evaluated the possible beneficial effects of T3 substitution in hypothyroid patients presenting with persistent depressive symptoms despite adequate replacement with levothyroxine alone.”
BackgroundNygaard, B., Jensen, E. W., Kvetny, J., Jarløv, A., & Faber, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0542 · Cited by 153
Hoang, T. D., Olsen, C. H., Mai, V. Q., Clyde, P. W., & Shakir, M. K. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4107 · Cited by 151
TSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
“Numerous trials [413–422] did not lead to a standard recommendation.”
BackgroundDevdhar, M., Ousman, Y. H., & Burman, K. D. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.04.008 · Cited by 190
Dayan, C. M., & Panicker, V. (2013) · European Thyroid Journal · doi:10.1159/000353777 · Cited by 142
Saravanan, P., Simmons, D. J., Greenwood, R., Peters, T. J., & Dayan, C. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1672 · Cited by 136
Celi, F. S., Zemskova, M., Linderman, J. D., Smith, S., Drinkard, B., Sachdev, V., Skarulis, M. C., Kozlosky, M., Csako, G., Costello, R., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1329 · Cited by 125
“A single study allowed dose titration, but the data reported were limited to QOL and psychological endpoints (21).”
MethodCombination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124
Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 154
Subclinical hypothyroidism increases the risk for depression in the elderly
Chueire, V. B., Romaldini, J. H., & Ward, L. S. (2006) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2006.02.001 · Cited by 141
Thyroid Dysfunction and Women's Reproductive Health
Redmond, G. P. (2004) · Thyroid · doi:10.1089/105072504323024543 · Cited by 119
“However, two additional recent double-blinded studies in hypothyroid patients comparing T 4 alone with T 4 plus T 3 did not find any difference in mood or cognitive function be-tween the two regimens (44,45).”
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114
Slawik, M., Klawitter, B., Meiser, E., Schories, M., Zwermann, O., Borm, K., Peper, M., Lubrich, B., Hug, M. J., Nauck, M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0297 · Cited by 113
Neuropsychiatric Manifestations of Thyroid Disease
Feldman, A. Z., Shrestha, R. T., & Hennessey, J. V. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.005 · Cited by 122
“But controlled studies have not documented success with this approach,(3,4) leaving the role of thyroid hormones in the treatment of euthyroid depression in question.(5) Likewise, combinations of LT3 and antidepressants in euthyroid patients, as well as LT3 with levothyroxine in fully replaced hypothyroid subjects, ha…”
BackgroundVan Der Deure, W. M., Appelhof, B. C., Peeters, R. P., Wiersinga, W. M., Wekking, E. M., Huyser, J., Schene, A. H., Tijssen, J. G. P., Hoogendijk, W. J. G., Visser, T. J., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03267.x · Cited by 97
Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism
Chao, M., Jiawei, X., Xia, H., Guoming, W., Yangang, W., Xufu, W., & Shuyao, Z. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32832c79e0 · Cited by 93
Shakir, M. K. M., Brooks, D. I., McAninch, E. A., Fonseca, T. L., Mai, V. Q., Bianco, A. C., & Hoang, T. D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab478 · Cited by 92
“Other trials prescreened and stratified patients for fatigue (28) or depressive symptoms (29).”
BackgroundAppelhof, B. C., Peeters, R. P., Wiersinga, W. M., Visser, T. J., Wekking, E. M., Huyser, J., Schene, A. H., Tijssen, J. G. P., Hoogendijk, W. J. G., & Fliers, E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0451 · Cited by 91
Hennemann, G., Docter, R., Visser, T. J., Postema, P. T., & Krenning, E. P. (2004) · Thyroid · doi:10.1089/105072504323030924 · Cited by 90
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Subclinical hypothyroidism, mood, and cognition in older adults: a review
Joffe, R. T., Pearce, E. N., Hennessey, J. V., Ryan, J. J., & Stern, R. A. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3796 · Cited by 88
“The studies in Table 2 are of limited value, and the value of the addition of T3, which has been used to treat depression, has not been clearly demonstrated (Sawka et al., 2003).”
BackgroundSelf-citationRodriguez, T., Lavis, V. R., Meininger, J. C., Kapadia, A. S., & Stafford, L. F. (2005) · Endocrine Practice · doi:10.4158/ep.11.4.223 · Cited by 80
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Self-citationFadeyev, V. V., Morgunova, T. B., Melnichenko, G. A., & Dedov, I. I. (2010) · Hormones · doi:10.14310/horm.2002.1274 · Cited by 77
Design of New Questionnaires to Measure Quality of Life and Treatment Satisfaction in Hypothyroidism
McMillan, C. V., Bradley, C., Woodcock, A., Razvi, S., & Weaver, J. U. (2004) · Thyroid · doi:10.1089/thy.2004.14.916 · Cited by 75
Liothyronine use in a 17 year observational population‐based study ‐ the tears study
Leese, G. P., Soto‐Pedre, E., & Donnelly, L. A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13052 · Cited by 75
Thyroxine replacement: a clinical endocrinologist’s viewpoint
Eligar, V, Taylor, P., Okosieme, O., Leese, G., & Dayan, C. (2016) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563216642255 · Cited by 72
“Parallel 44 No No No – – – Sawka et al.(110) Parallel 40 No No No – – – Fadeyev et al.”
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 86
Valizadeh, M., Seyyed-Majidi, M. R., Hajibeigloo, H., Momtazi, S., Musavinasab, N., & Hayatbakhsh, M. R. (2009) · Endocrine Research · doi:10.1080/07435800903156340 · Cited by 65
“The findings of our study that combination of LT4 and LT3 provides no significant on patients’ psychosocial outcomes relative to only LT4 therapy support the results previously found by either crossover (18,19,23) or paralleldesign (17,21,22) randomized trials.”
ResultCeli, F. S., Zemskova, M., Linderman, J. D., Babar, N. I., Skarulis, M. C., Csako, G., Wesley, R., Costello, R., Penzak, S. R., & Pucino, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03700.x · Cited by 65
Dayan, C., & Panicker, V. (2018) · Thyroid Research · doi:10.1186/s13044-018-0045-x · Cited by 62
Millan-Alanis, J. M., González-González, J. G., Flores-Rodríguez, A., Singh Ospina, N., Maraka, S., Moreno-Peña, P. J., Brito, J. P., González-Velázquez, C., & Rodríguez-Gutiérrez, R. (2021) · Thyroid® · doi:10.1089/thy.2021.0270 · Cited by 60
Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism
Idrees, T., Palmer, S., Maciel, R. M. B., & Bianco, A. C. (2020) · Thyroid® · doi:10.1089/thy.2020.0153 · Cited by 58
Diagnosis and Treatment of Hypopituitarism: An Update
van Aken, M. O., & Lamberts, S. W. J. (2005) · Pituitary · doi:10.1007/s11102-006-6039-z · Cited by 72
“tients is not effective in improving physical functioning according to most studies [27,28].”
BackgroundJoffe, R. T., Brimacombe, M., Levitt, A. J., & Stagnaro-Green, A. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.5.379 · Cited by 57
Self-citationHypothyroidism and depression: salient aspects of pathogenesis and management.
Duntas, L. H., & Maillis, A. N. (2013) · PubMed · Cited by 72
Kaplan, M. M., Sarne, D. H., & Schneider, A. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031436 · Cited by 56
“(8) report a comparison of T4 plus T3 vs.”
BackgroundHennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
Samuels, M. H., & Bernstein, L. J. (2022) · Thyroid · doi:10.1089/thy.2022.0139 · Cited by 64
“An earlier trial conducted in patients with depressive symptoms (49) found no improvement in HRQoL or mood with LT4/LT3.”
Schweizer, R., Martin, D. D., Schwarze, C. P., Binder, G., Georgiadou, A., Roth, J., & Ranke, M. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032254 · Cited by 49
“On the basis of the mean densitometric data reported by Benbassat et al. (1), using the method of Katzman et al. ( 4 ), we derived additional bone parameters, such as BV and BA/BV ratio, from their patients and controls [lumbar spine, BV 112.7 cm3 and 277.2 cm3 ( 59%); BA/BV ratio, 0.21 and 0.15 ( 29%), respectively;…”
InfluentialHormone Replacement After Thyroid and Parathyroid Surgery
Schäffler, A. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0827 · Cited by 68
Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?
Wiersinga, W. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0879 · Cited by 45
Tariq, A., Wert, Y., Cheriyath, P., & Joshi, R. (2018) · Southern Medical Journal · doi:10.14423/smj.0000000000000823 · Cited by 43
Razvi, S., McMillan, C. V., & Weaver, J. U. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02381.x · Cited by 43
Combination L-T3 and L-T4 therapy for hypothyroidism
Wartofsky, L. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000432611.03732.49 · Cited by 42
Kaminski, J., Miasaki, F. Y., Paz-Filho, G., Graf, H., & Carvalho, G. A. D. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000192 · Cited by 42
“Most studies have assessed changes in mood, cognition function and QoL during combination therapy with LT4/LT3 (11,12,21,2326,28,30-32,40,41).”
BackgroundResultPhysician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2018) · Thyroid · doi:10.1089/thy.2018.0325 · Cited by 41
Guglielmi, R., Frasoldati, A., Zini, M., Grimaldi, F., Gharib, H., Garber, J. R., & Papini, E. (2016) · Endocrine Practice · doi:10.4158/ep161308.or · Cited by 39
Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level
Jonklaas, J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000355 · Cited by 38
Akirov, A., Fazelzad, R., Ezzat, S., Thabane, L., & Sawka, A. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00477 · Cited by 37
Self-citationLiothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality
Planck, T., Hedberg, F., Calissendorff, J., & Nilsson, A. (2021) · Thyroid® · doi:10.1089/thy.2020.0388 · Cited by 35
Combined T4 and T3 Therapy—Back to the Drawing Board
Cooper, D. S. (2003) · JAMA · doi:10.1001/jama.290.22.3002 · Cited by 35
TSH may not be a good marker for adequate thyroid hormone replacement therapy
Alevizaki, M., Mantzou, E., Cimponeriu, A. T., Alevizaki, C. C., & Koutras, D. A. (2005) · Wiener klinische Wochenschrift · doi:10.1007/s00508-005-0421-0 · Cited by 34
“It should be noted that in some recent studies parameters of thyroid function were not always normal after the shift [21], that only patients with depressive symptoms were specifically examined [22] and that the number examined was small [20]; thus none of these studies can be considered conclusive [23].”
ResultThyroid hormone replacement: current status and challenges
Okosieme, O. E. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600307 · Cited by 35
“Briefly, some protocols used fixed T3 doses in combination with varying amounts of T4 resulting in a range of T3:T4 ratios that do not mimic the human thyroid secretion ratio of 1:14 (Table 2) [83-85,88-90,93-95].”
BackgroundMethodInfluentialRegalbuto, C., Maiorana, R., Alagona, C., Paola, R. D., Cianci, M., Alagona, G., Sapienza, S., Squatrito, S., & Pezzino, V. (2007) · Thyroid · doi:10.1089/thy.2006.0084 · Cited by 32
New questions regarding bioequivalence of levothyroxine preparations: A Clinician's response
Green, W. L. (2005) · The AAPS Journal · doi:10.1208/aapsj070107 · Cited by 34
Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2019) · Thyroid · doi:10.1089/thy.2018.0369 · Cited by 31
Kraut, E., & Farahani, P. (2015) · Clinical and Investigative Medicine · doi:10.25011/cim.v38i6.26194 · Cited by 30
Escobar-Morreale, H. F., Botella-Carretero, J. I., & Morreale de Escobar, G. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.10.004 · Cited by 30
DiStefano, J., & Jonklaas, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00746 · Cited by 28
“When examining outcomes of either quality of life, mood, or neurocognitive function, trials fall into 3 broad categories: those showing substantial clinical benefit of combination therapy (11, 16), those showing partial benefit based on some outcome measures, but not others (10, 13, 18, 21), and those showing no benef…”
BackgroundRisks and safety of combination therapy for hypothyroidism
Jonklaas, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1182019 · Cited by 27
Optimizing Treatment of Hypothyroidism
Clarke, N., & Kabadi, U. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403040-00003 · Cited by 29
Lan, H., Wen, J., Mao, Y., Huang, H., Chen, G., & Lin, W. (2022) · Clinical Endocrinology · doi:10.1111/cen.14742 · Cited by 26
Borson‐Chazot, F., Terra, J., Goichot, B., & Caron, P. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071386 · Cited by 37
“Most studies of combination therapy did not evidence a difference in QoL for LT4 + LT3 combination therapy, relative to LT4 alone [25,47,48,50,51,60].”
BackgroundMethodInfluentialThe Challenges and Complexities of Thyroid Hormone Replacement
Kansagra, S. M., McCudden, C. R., & Willis, M. S. (2010) · Laboratory Medicine · doi:10.1309/lmb39th2fzgndgim · Cited by 34
Jonklaas, J., Tefera, E., & Shara, N. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00031 · Cited by 23
Tandon, A., Singh, R., Gupta, S., & Saroja, K. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_165_17 · Cited by 21
“Studies in thyroidectomized rats have shown that replacement therapy with LT alone is not enough to achieve euthyroidism in all tissues and adding LT3 with LT4 helps in achieving all tissue euthyroidism and improves mood and neurocognition.[8,9] However, later trials investigating the effect of combined treatment with…”
BackgroundResultSubclinical Hypothyroidism after 131I-Treatment of Graves’ Disease: A Risk Factor for Depression?
Yu, J., Tian, A., Yuan, X., & Cheng, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154846 · Cited by 25
Sub-laboratory hypothyroidism and the empirical use of Armour thyroid.
Gaby, A. R. (2004) · PubMed · Cited by 23
Perros, P. (2012) · European Thyroid Journal · doi:10.1159/000338637 · Cited by 20
Wartofsky, L. (2004) · Thyroid · doi:10.1089/105072504323030898 · Cited by 22
Sesmilo, G., Simó, O., Choque, L., Casamitjana, R., Puig-Domingo, M., & Halperin, I. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.09.006 · Cited by 18
Peripheral Thyroid Hormone Conversion and Its Impact on TSH and Metabolic Activity
Holtorf, K. (2014) · Journal of Restorative Medicine · doi:10.14200/jrm.2014.3.0103 · Cited by 21
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design
Madan, R., & Celi, F. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00371 · Cited by 18
Does Combination T4 And T3 Therapy Make Sense?
McDermott, M. T. (2012) · Endocrine Practice · doi:10.4158/ep12076.ra · Cited by 18
Environment and Thyroid Function
Burger, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0332 · Cited by 15
“More recent articles have not been able to confirm these findings, but they were done in completely different settings, the first one in Lithuania, the other in Australia and North America (34, 35).”
ResultThyroid Medications During Pregnancy
Bach-Huynh, T.-G., & Jonklaas, J. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000211834.41844.82 · Cited by 16
Trastornos del ánimo, psicofármacos y tiroides
Danilo Quiroz, L., Sergio Gloger, K., Sergio Valdivieso, F., Ivelic, J. A., & Carlos Fardella, B. (2004) · Revista médica de Chile · doi:10.4067/s0034-98872004001100012 · Cited by 14
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Hypothyroidism and Hyperthyroidism
Skugor, M., & Fleseriu, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00062-x · Cited by 13
Bahl, S., Taylor, P. N., Premawardhana, L. D., Stedman, M., Heald, A., Dayan, C. M., & Okosieme, O. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf449 · Cited by 11
Nassar, M., Hassan, A., Ramadan, S., Desouki, M. T., Hassan, M. A., & Chaudhuri, A. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01612-6 · Cited by 12
“Most of the included studies are insignificant [9, 12–18] except for two studies, one showed a lower TSH, and the other showed a higher TSH [19, 20].”
ResultDose administration time from before breakfast to before dinner affect thyroid hormone levels?
Ala, S., Akha, O., Kashi, Z., Asgari, H., Bahar, A., & Sasanpour, N. (2015) · PubMed Central · Cited by 13
Chen, Y., & Tai, H.-Y. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0583 · Cited by 16
“We ultimately identified a total of 25 studies [7-34] that met the inclusion criteria for this metaanalysis, including 1,735 patients.”
BackgroundLatrofa, F., & Pinchera, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-517-6_7 · Cited by 15
Metadata
- Authors
- Sawka, A. M., Gerstein, H. C., Marriott, M. J., MacQueen, G. M., & Joffe, R. T.
- Affiliations
- McMaster University (CA)
- Hamilton Health Sciences (CA)
- St Joseph's Health Care (CA)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Gerstein, H. C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-10
- Volume
- 88
- Issue
- 10
- Pages
- 4551-4555
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2086555083
- Cited by
- 175
- References
- 26
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 11 · 2015: 5 · 2014: 6 · 2013: 6 · 2012: 9
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McMaster University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- hypothyroidism, depressive symptoms, levothyroxine, triiodothyronine, combination thyroid hormone therapy, thyroid hormone replacement, mood, well-being, thyroid-stimulating hormone
- MeSH terms
- Adult, Affect, Depression, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypothyroidism, Male, Middle Aged, Thyroid Gland, Thyroxine, Triiodothyronine, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.